Hepatitis C Virus (HCV) Infection Withdrawn Phase 4 Trials for Sofosbuvir (DB08934)

Also known as: Hepatitis C (HCV) / HCV Infection / HCV Infections / HCV / Hepatits C / Hepatitis C Virus (HCV) / Hepatitis C Virus / Hepatitis C virus test

IndicationStatusPhase
DBCOND0052122 (Hepatitis C Virus (HCV) Infection)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03389061Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole TabletOther
NCT03105349A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5ATreatment